Announced by CTBC FHC on behalf of CTBC Bank Overseas Branches for proposed acquisition of the Subordinated Bonds of Taiwan Life Singapore Pte. Ltd.

1.Name and nature of the underlying assets (if preferred shares, the terms
and conditions of issuance shall also be indicated, e.g., dividend yield,
etc.):The Subordinated Bonds of Taiwan Life Singapore Pte. Ltd.
2.Date of occurrence of the event: 2026/09/24
3.Date of the board of directors resolution: 2026/09/24
4.Other approval date:N/A
5.Amount, unit price, and total monetary amount of the transaction:
(1)Amount:No more than US$100,000,000
(2)Unit price: To be announced following pricing
(3)Total monetary amount:No more than US$100,000,000
6.Trading counterparty and its relationship with the Company (if the trading
counterparty is a natural person and furthermore is not a related party of
the Company, the name of the trading counterparty is not required to be
disclosed):
(1)Trading counterparty:Taiwan Life Singapore Pte. Ltd.
(2)Relationship with the Company: CTBC Bank and Taiwan Life Singapore Pte.
Ltd. are both subsidiaries of CTBC FHC
7.Where the trading counterparty is a related party, announcement shall also
be made of the reason for choosing the related party as trading counterparty
and the identity of the previous owner, its relationship with the Company
and the trading counterparty, and the previous date and monetary amount of
transfer:Proposed to act as the underwriter in connection with offering and
issuance of The Subordinated Bonds of Taiwan Life Singapore Pte. Ltd.
8.Where an owner of the underlying assets within the past five years has
been a related party of the Company, the announcement shall also include the
date and price of acquisition and disposal by the related party, and its
relationship with the Company at the time of the transaction:N/A
9.Matters related to the current disposal of creditors' rights (including
types of collaterals of the disposed creditor’s rights; if creditor's
rights over a related party, announcement shall be made of the name of the
related party and the book amount of the creditor's rights, currently being
disposed of, over such related party):N/A
10.Profit or loss from the disposal (not applicable in cases of acquisition
of securities) (those with deferral should provide a table explaining
recognition):N/A
11.Terms of delivery or payment (including payment period and monetary
amount), restrictive covenants in the contract, and other important terms
and conditions:Lump-Sum Payment on Settlement Date; None
12.The manner of deciding on this transaction (such as invitation to tender,
price comparison, or price negotiation), the reference basis for the
decision on price, and the decision-making unit:
(1)The manner of deciding on this transaction:Bookbuilding
(2)The reference price: Market price
(3)The decision-making unit:Approved by the Board and internal authorization
13.Net worth per share of the Company's underlying securities acquired or
disposed of:N/A
14.Cumulative no.of shares held (including the current transaction), their
monetary amount, shareholding percentage, and status of any restriction of
rights (e.g., pledges), as of the present moment: CTBC FHC: None;
CTBC Bank:
Unit: Determined within the total amount of no more than US$100,000,000;
Total amount: No more than US$100,000,000;
Status of any restriction of rights:None
15.Current ratio of securities investment (including the current trade, as
listed in article 3 of Regulations Governing the Acquisition and Disposal of
Assets by Public Companies) to the total assets and equity attributable to
owners of the parent as shown in the most recent financial statement and
working capital as shown in the most recent financial statement as of the
present:Ratio to Total Assets: 28.32%; Ratio to Equity: 392.77%;
Working Capital:N/A
16.Broker and broker's fee:N/A
17.Concrete purpose or use of the acquisition or disposal:Proposed to act as
the underwriter in connection with the Subordinated Bonds of
Taiwan Life Singapore Pte. Ltd. to assist sales and settlement related issues
18.Any dissenting opinions of directors to the present transaction:No
19.Whether the counterparty of the current transaction is
a related party:Yes
20.Date of ratification by supervisors or approval by
the Audit Committee:2026/09/23
21.Whether the CPA issued an unreasonable opinion regarding the current
transaction:N/A
22.Name of the CPA firm:N/A
23.Name of the CPA:N/A
24.Practice certificate number of the CPA:N/A
25.Whether the transaction involved in change of business model:No
26.Details on change of business model:N/A
27.Details on transactions with the counterparty for the past year and the
expected coming year:N/A
28.Source of funds:Working Capital
29.Date on which material information regarding the same event
has been previously released:NA
30.Any other matters that need to be specified: The proposed acquisition of
the bonds and all other related conditions are subject to the execution of
the final transaction agreements, the obtaining of all required approvals
from the relevant competent authorities for this transaction, as well as the
applicable timeline and prevailing market conditions.
USD transaction, USD:NTD=1:31.893